Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial

Ian Judson*, James P. Morden, Lucy Kilburn, Michael Leahy, Charlotte Benson, Vivek Bhadri, Quentin Campbell-Hewson, Ricardo Cubedo, Adam Dangoor, Lisa Fox, Ivo Hennig, Katy Jarman, Warren Joubert, Sarah Kernaghan, Antonio López Pousa, Catriona McNeil, Beatrice Seddon, Claire Snowdon, Martin Tattersall, Christy TomsJavier Martinez Trufero, Judith M. Bliss

*Corresponding author for this work

Research output: Contribution to journal › Article (Academic Journal) › peer-review

79 Citations (Scopus)
171 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trial'. Together they form a unique fingerprint.

Medicine and Dentistry